Activation_signals_leading_to_proliferation_of_normal_and_leukemic_CD3+_large_granular_lymphocytes._The_activation_signals_leading_to_proliferation_of_normal_and_leukemic_CD3+_large_granular_lymphocytes_(LGL)_were_studied_in_vitro._Anti-CD3_monoclonal_antibody_(MoAb)_alone_(P_less_than_.01)_and_recombinant_interleukin-2_(IL-2)_alone_(P_less_than_.01)_caused_significant_stimulation_of_peripheral_blood_mononuclear_cells_(PBMC)_from_four_CD3+_LGL_leukemia_patients,_as_measured_in_a_3H-thymidine_incorporation_assay._Recombinant_interleukin-4_(IL-4)_alone_had_no_effect_(P_=_.11)._The_combination_signals_of_anti-CD3_MoAb_and_either_IL-2_or_IL-4_produced_a_proliferative_response_greater_than_anti-CD3_MoAb_alone_(P_less_than_.01)_or_lymphokine_alone_(P_less_than_.01)._Leukemic_LGL,_purified_by_two-color_sorting,_were_subsequently_activated_by_anti-CD3_MoAb_and_IL-2_and_assessed_for_DNA_content_by_viable_Hoechst_No._33342_(HO)_staining._Results_of_these_studies_demonstrated_that_leukemic_LGL_were_stimulated_directly_by_anti-CD3_MoAb_and_IL-2,_with_the_percentage_of_cells_in_cell_cycle_(S_+_G2/M)_ranging_from_16%_to_72%._Normal_CD3+_LGL_were_also_stimulated_to_enter_the_cell_cycle_by_anti-CD3_and_IL-2._These_results_show_that_leukemic_LGL_proliferate_in_vitro_after_activation_through_the_T-cell_receptor_and/or_lymphokine.